Mankind Pharma 

₹2,682.95
20
-₹33.05-1.22% Thursday 10:00

Statistik

Harga Tertinggi Hari Ini
-
Harga Terendah Hari Ini
-
52M Tinggi
-
52M Rendah
-
Volume
-
Rata-Rata Volume
-
Kap Pasar
1.09T
Rasio P/E
55.45
Hasil Dividen
-
Dividen
-

Mendatang

Pendapatan

29OctDiharapkan
Q2 2023
Q4 2023
Q1 2024
Q2 2024
Berikutnya
9.62
11.11
12.6
14.09
EPS yang Diharapkan
T/A
EPS Aktual
T/A

Orang Juga Mengikuti

Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti MANKIND.NSE. Ini bukan rekomendasi investasi.

Peserta

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Show more...
CEO
Mr. Ramesh C. Juneja
Karyawan
19540
Negara
IN
ISIN
INE634S01028

Daftar